- Research
- Open access
- Published:
Infection prevention and control in 2030: a first qualitative survey by the Crystal Ball Initiative
Antimicrobial Resistance & Infection Control volume 13, Article number: 88 (2024)
Abstract
Background
Healthcare delivery is undergoing radical changes that influence effective infection prevention and control (IPC). Futures research (short: Futures), the science of deliberating on multiple potential future states, is increasingly employed in many core societal fields. Futures might also be helpful in IPC to facilitate current education and organisational decisions. Hence, we conducted an initial survey as part of the IPC Crystal Ball Initiative.
Methods
In 2019, international IPC experts were invited to answer a 10-item online questionnaire, including demographics, housekeeping, and open-ended core questions (Q) on the “status of IPC in 2030” (Q1), “people in charge of IPC” (Q2), “necessary skills in IPC” (Q3), and “burning research questions” (Q4). The four core questions were submitted to a three-step inductive and deductive qualitative content analysis. A subsequent cross-case matrix produced overarching leitmotifs. Q1 statements were additionally coded for sentiment analysis (positive, neutral, or negative).
Results
Overall, 18 of 44 (41%) invited experts responded (from 11 countries; 12 physicians, four nurses, one manager, one microbiologist; all of them in senior positions). The emerging leitmotifs were “System integration”, “Beyond the hospital”, “Behaviour change and implementation”, “Automation and digitalisation”, and “Anticipated scientific progress and innovation”. The statements reflected an optimistic outlook in 66% of all codes of Q1.
Conclusions
The first exercise of the IPC Crystal Ball Initiative reflected an optimistic outlook on IPC in 2030, and participants envisioned leveraging technological and medical progress to increase IPC effectiveness, freeing IPC personnel from administrative tasks to be more present at the point of care and increasing IPC integration and expansion through the application of a broad range of skills. Enhancing participant immersion in future Crystal Ball Initiative exercises through simulation would likely further increase the authenticity and comprehensiveness of the envisioned futures.
Introduction
Healthcare delivery faces significant challenges and disruptive changes [1]. These challenges have triggered an interest in possible future developments and strategic discussions on a global level. For example, the Future Today Institute (https://futuretodayinstitute.com) considers public health as one of the macro forces that provide important signals for predicting technological trends. One of the United Nations’ Sustainable Development Goals is to ensure healthy lives and promote well-being for all by 2030 (https://sdgs.un.org/goals). The experience of the COVID-19 pandemic has accelerated this process and propelled IPC to centre stage. However, healthcare-associated infections (HAI) continue to cause patient suffering and loss of life, prolong medical treatment, and accelerate antimicrobial resistance, despite their preventability [2]. Over the last 25 years, numerous large-scale initiatives have been launched to address these problems, but they tend to be reactive and not focused on the future.
Looking into possible, more distant futures and spelling out visions for IPC might help guide current efforts and open the mind to see the present-day challenges and positively influence developments and uptake of innovation. This could benefit decision-making for designing workforce training, revising healthcare organisational structures, investing in architectural and electronic infrastructure, and advancing science. Futures research, or Futures, has evolved over the last 20 years into a field of scientific inquiry into what the world might look like far ahead [3]. As the most productive methodologic innovation, Futures has moved from “predicting the future to mapping alternative futures […], both at external collective levels and individual inner levels” [4]. The field has further benefited from growing operational experience and further innovations, e.g., the real-time Delphi method by The Millennium Project [5] or the Experiential Futures ‘Show and tell’ approach to “…design situations that help us understand possible futures by visiting them” [6]. Not surprisingly, healthcare holds a privileged place in Futures research [1].
The interest in a more radical and systematic exploration of the potential futures of IPC was initially triggered by strategic sessions within Swissnoso, the Swiss Centre for Infection Prevention (https://www.swissnoso.ch), and evolved from there in informal discussions with experts at international conferences and other occasions. Due to the great interest, we created the Crystal Ball Initiative as an ongoing platform for Futures research in IPC open to interested parties and further research initiatives [7]. Here, we present the qualitative analysis of the first survey conducted in 2019, shortly before the onset of the SARS-CoV-2 pandemic.
Methods
Study design
A transversal qualitative survey study based on open questions [8].
Participants
In January 2019, we invited a purposive sample of 44 multinational Infection Prevention and Control (IPC) experts with nursing and physician backgrounds to participate. They were selected based on their innovative approaches to IPC as manifested by their leadership in scientific publications, global and national leadership positions, contributions to international and national organisations and initiatives, professional conferences as speakers, and social media presence.
Data collection
The online questionnaire was created to anticipate future developments in IPC in research and practice relevant to strategic development for IPC experts, funding agencies, policymakers and healthcare managers. Brevity and clarity were design requirements to increase the return rate with busy experts. Various formulations were developed iteratively by a working group of IPC expert nurses, physicians, a psychologist, and a data analyst. IPC volunteer experts were asked to test the questionnaire versions using a ‘think-aloud’ technique, i.e., constantly voicing their thoughts while reading and answering questions. This process led to four free-text core questions (Q1-Q4) and seven “housekeeping” questions (Table 1). The online self-administered survey (Survey Monkey by momentive.ai) was opened in January 2019 with an invitation sent to the 44 selected IPC experts – followed by a reminder in February 2019 – and closed in March 2019.
Analysis
Two researchers performed a structured qualitative analysis (HS, JM) of the core questions. First, one author (HS) labelled each statement in the respondents’ answers to core questions Q1–Q4 separately with a code, favouring the respondent’s terminology for code names (Fig. 1), while a second author (JM) ‘proofread’ the coding, and concerns were resolved in a bilateral discussion. These codes were then inductively grouped into themes within each core question. Next, themes were further grouped under “leitmotifs” that held true across the core questions. The two authors (HS, JM) additionally evaluated all coded statements in the answers to Q1, whether they were formulated in a positive, negative, or neutral tone for sentiment analysis. Concerns were resolved through discussion. Finally, the results were submitted to the respondents for ‘member checking’ in the form of an early manuscript draft of this publication to ensure that the results were complete and accurate [8].
Results
Overall, 18 of the 44 (41%) invited responded; six from the USA, two from Canada and Switzerland, and one each from Australia, Austria, France, Germany, Mexico, Singapore, The Netherlands, and The United Kingdom; 12 were physicians, four were nurses, one had a healthcare management background, and one was a microbiologist by education, all with higher education and in senior positions. The cross-question analysis produced the five leitmotifs (Fig. 2) subsequently presented in detail. The subjective connotation of the answers to Q1 in terms of the desirability of future states of IPC, was positive in 66%, negative in 15%, and neutral in 19% of cases. Based on Q4, Table 2 highlights suggested skills and roles for IPC in 2030 and Table 3 lists essential research for the envisioned futures.
“System integration”
These days, IPC generally constitutes a separate unit of IPC professionals in hospitals. However, participants questioned this traditional thinking and projected an increase in organisational system integration. This extends to economics and quality of care measures. IPC has also to adapt to the accelerating shift of medical care to outpatient and long-term settings.
Quote: “Infection prevention must be perceived as a system rather than a specific programme.”
By 2030, IPC leaders will play an integrative role in patient safety by connecting the current players. One participant foresaw IPC leaders proactively breaking traditional silos and occupying influential roles as advocates for safer healthcare. However, in a pessimistic outlook, IPC teams will be absorbed by antibiotic stewardship or quality management programs, which could be associated with an undesirable loss of IPC-specific know-how.
Quote: “IPC nirvana in 2030 will see IPC integrated across every aspect of healthcare and the role of IPC experts shrinking to be more influencers and leaders and fewer coveters of technical know-how. IPC is and will be stronger and more influential if we (the IPC community) secure a strong voice at the global health table. If we do not, others jump in and take our place, and almost without exception, those “others” lack experience/expertise, capability, and competence to talk with depth and understanding on IPC.”
IPC teams need a broader range of knowledge and skills than today (Table 2). Among these, understanding complex systems was stated explicitly.
Quote: “I think the infection prevention and control/hospital epidemiology field will need to rethink the skillsets needed on the team to optimise the success of programs.”
Quote: “Knowledge about complex care practices.”
A strong emphasis was put on the presence of nurses and physicians in IPC teams and their presence as observers and coaches, face-to-face with care providers. In addition, the future patient will have a role in IPC, will be educated and empowered as a healthcare ‘consumer’ and will be involved in co-creating the care processes and IPC measures.
Research and development will provide the best organisational models and integration of IPC in various healthcare contexts, such as the increasingly dominant outpatient care sector (Table 3). Furthermore, since financial constraints will have become even more relevant for healthcare institutions by 2030, IPC constitutes a driving force in cost-saving based on a more robust calculation of the costs imposed by HAI and costs generated by prevention measures than is the case today.
Quote: “2030 is just 11 years away. Looking back 11 years ago to 2008 as a comparator, I think we have to be realistic and conclude that IPC in 2030 will be fairly similar to what it is today.”
System integration also concerns a better understanding of HAI and the ever-expanding role of the microbiome. Microbiology’s role will be considered more holistically, beyond its current focus on single pathogens, accounting for, e.g., the transmission of virulence factors and resistance elements between patients, and between patient and environmental microbiota.
“Beyond the hospital”
Some respondents foresaw that by 2030 IPC responsibilities and activities will have transcended today’s institutional boundaries.
Quote: “IPC has to move out of its comfort zone and get around the table with health systems and health security leaders – we need a serious voice – not others talking on our behalf. In every country of the world, we need IPC leaders who could fulfil the roles of chief medical officer or chief nursing officer within ministries of health.”
In an undesirable future, however, the heightened governmental interest in IPC could become dominant and lead to over-regulation and poor adaptation of policies according to local needs.
Per the responders, challenges to be tackled by IPC in 2030 include climate change, human migration, emerging diseases, political influence, global health threats, lack of potable water, emerging technologies, and the slow uptake of modern IPC in low-to-middle-income countries.
Quote: “How are we prepared to deal with public health and national or international emergencies?”
Quote: “IPC does not yet “own” the low- and middle-income countries space.”
However, some respondents suggested that IPC in low- and middle-income will be better understood in 2030 thanks to dedicated research.
“Behaviour change and implementation”
By 2030, bench-to-bedside translation will be a central activity of IPC teams. IPC will produce globally recognised behavioural and implementation scientists. They will use behaviour change instruments such as ‘nudging’ and Plan-Do-Study-Act (PDSA) cycles for continuous system improvement more readily. Additionally, performance monitoring and feedback will be optimised, and research will have identified the most effective implementation frameworks.
Dissemination of best IPC practices will benefit from innovative educational techniques such as simulation [9], e-learning, virtual reality [10], and ‘serious games’ [11]. Interventions will be more successful because they can be systematically based on better scientific evidence that will have accumulated. IPC content will be an established part of undergraduate curricula.
Quote: “[…] What is much harder is figuring out “how” we will manage to implement these goals. So “soft skills” will be extremely important. Human relationships, diplomacy, compromise, listening, team building capacity, leadership, showing gratefulness, etc.”
Leadership enabled with strong social and communication skills will be essential for the sustainable success of IPC within healthcare systems.
Quote: “First and foremost, leadership development and an understanding of the value of developing strong and effective IPC leaders, empowered to take IPC where it needs to go and to get IPC understood by those who need to understand it.”
As mentioned in the leitmotif “System integration”, patient education and participation in IPC will support the implementation of preventive measures in two ways, by their own adherence, e.g., by toothbrushing for non-ventilator-associated pneumonia prevention, and by reminding healthcare providers in case of forgetting to apply their preventive tasks.
“Automation and digitalisation”
Data will be accessible to IPC teams through automated analytics and queries. Typical data sources include electronic medical records, laboratories, patient feedback, and multiple sensors. In addition, invasive devices are electronically identified and contribute to risk management on individual and institutional levels.
Quote: “The surveillance for infections will be fully automated, leaving the IP team free to put eyes on high-risk areas to identify risks, assess compliance with protocols, and provide just-in-time coaching. Video auditing will assist with the eyes on the component of the job - to enhance the reach of the human IPC resources. Radio Frequency Identification (RFID) or similar tech will be added to all indwelling devices and interact with the electronic medical record to automate device day counts, which will feed into the automated surveillance system. IPC protocols will be embedded into electronic medical records to provide real-time clinical guidance. Decision support regarding testing and treatment for infections will also be a component of the medical record.”
Intelligent surveillance systems will continuously scan data to highlight abnormal phenomena, e.g., an increase in the incidence of bloodstream infections, and point to system failures at an early stage. Caregivers will receive recommendations for personalised preventive measures within their patients’ electronic medical records. IPC teams will base their work on dashboards with highly automated data pre-processing and respond to real-time alerts. For example, dashboards will highlight daily ‘hot spots’ and trigger immediate measures. Context- and time-sensitive mobile educational IPC content will reach caregivers on the go. Digital coaching systems will observe caregivers during their daily work and provide real-time feedback on adherence issues.
This shift to automation calls for new IPC skill sets and work routines. Here, the views of survey participants diverged. In one possible future, artificial intelligence will make human epidemiologic know-how obsolete, shifting the focus to socio-adaptive expertise and allowing teams to spend their time in hospital wards for coaching and problem scouting. In an alternative future, however, IPC teams will require much more epidemiology and data science skills than today.
Quote: “Familiarity and expertise in data management, statistical analysis of data, epidemiological principles, use of artificial intelligence, methods for recognition and investigation of clusters or outbreaks of HAIs, knowledge of antimicrobial resistance patterns of pathogens.”
Artificial intelligence will also support bench-to-bedside translation. IPC-relevant scientific evidence will be captured and funnelled by machine learning to IPC teams and even frontline care providers in an actionable format, constantly keeping policies up-to-date.
Research involving automated surveillance of microbiology results will intensify and lead to a better understanding of the importance of patient, caregiver, and environmental microbiota and transmission pathways. Advances in calculation power, machine learning, and rapid genetic typing will enable real-time mapping of colonisation and infections. HAI definitions will have to adapt to this automation. Point-of-care testing will replace laboratory-based testing and will be guiding patient isolation.
More detailed digital information on each patient reduces the need for physical proximity with patients, which reduces pathogen transmission.
“Anticipated scientific progress and innovation”
Dedicated research will lead to a better understanding of transmission pathways, which will inform hospital and policy design.
Quote: “What is the relative importance of the various routes of transmissions (direct contact vs indirect contact-environment vs. droplet vs airborne)?”
Quote: “What is the relative value of various infection control strategies in the prevention of infections and the prevention of the spread of multi-resistant organisms (e.g., basic precautions vs additional precautions vs antibiotic stewardship)?”
Scientific evidence will transform hospital design, e.g., single rooms will be the standard, redesigned shower drains and sewage systems will prevent pathogen aerosolisation, and improved design of personal protective equipment will guarantee caregiver safety.
IPC teams will have adopted health technology more profoundly. An improved concept for hand hygiene will likely have emerged, facilitating caregiver training and behaviour. Techniques to render pathogens visible will support adherence to IPC measures further. Hand hygiene products could be enhanced with microbial remnant-interacting components, given their benefit for HAI prevention will have been proven.
In one imagined future, vaccines against hospital pathogens will have revolutionised IPC based on a better understood host–pathogen interaction. The human microbiome will be amenable to manipulations to reduce infection risks.
Quote: “What is the role of the microbiome and immunologic host factors in the risk of HAI, and how can these be 'manipulated' or included in the prevention of infections?”
On the other hand, medical progress will constantly produce new infectious risks and call for adapted IPC strategies.
Discussion
Humans tend to rely on established reasoning to solve current challenges. This also applies to the field of IPC. In contrast, systematically exploring a range of possible futures can help manage uncertainties, build resilience, and prepare clinicians to respond to new challenges more rapidly and appropriately. The global IPC experts who participated in this qualitative inquiry saw a positive future with IPC being more integrated into the healthcare systems, reaching beyond the inpatient sector and acute care, making better use of tools for behavioural change and diffusion of knowledge, and benefitting from further scientific discovery while leveraging technology to automate data collection and analysis for both infection surveillance and behaviour monitoring. However, participants also raised concerns about the sustained spread of multidrug-resistant organisms and the slow development of IPC in low- and middle-income countries. In addition, they stressed the need to keep IPC rooted in clinical medicine and present ‘at the sharp end’ where patient care happens.
The participants envisioned the future as predominantly positive. This optimistic attitude is noteworthy. Technological advances are imagined as helping free IPC staff from repetitive office work and allowing them to be more present at the frontline of patient care. Thereby, IPC is projected to ideally evolve in two directions, by increasing the benefit of technology and automation on the one hand and fostering typical human skills such as mindful social behaviour and face-to-face exchange (‘soft skills’). Fears of data breaches, flawed artificial intelligence, and the ongoing difficulties with IT integration did apparently not trigger significant concern. This optimistic view might be due to a natural professional bias among preventionists towards proactive system improvement.
Of note, this survey occurred in the year before the SARS-CoV-2 pandemic. Since then, the views expressed in this survey might have changed substantially. This would justify a repetition of this survey. Interestingly, some participants anticipated the possibility of a large-scale pandemic and questioned whether preparations were sufficient. It is unique to have captured a reflection of expert views of possible futures so close to this global disruption of healthcare that ended up propelling IPC into the mainstream.
IPC “system integration” was a central theme. Participants expressed concern that essential expertise would be lost if core IPC practices were to be overseen by quality managers. This apprehension touches on the contrasting cultural roots of patient safety efforts between quality management and clinically oriented IPC [12]. Participants emphasised the universal importance of clinical experience in IPC and leadership by IPC experts that should not be lost. This view was confirmed shortly after the survey when the pandemic resulted in the sudden urgency to incorporate IPC dimensions into healthcare structures and policies at the institutional, national, and international levels. It should be noted here that the value of IPC expertise goes beyond the healthcare spectrum. As the pandemic continued, the involvement of experienced IPC experts at the government policymaking level was employed in some countries to strengthen the effectiveness of risk communication in the public sphere. Indeed, as Read et al. have highlighted, residents in the UK had a more robust knowledge of IPC after the emergence of COVID-19, suggesting a more general need for IPC education [13].
Despite this unresolved matter, the question about the IPC position in healthcare (Q2: “In whose hands will infection prevention in healthcare settings lay in 2030? Who will be responsible for IPC within healthcare organisations?”) did not produce codes for the leitmotif “Anticipated scientific progress and innovation.” Hence, there might still be an opportunity for organisational research to identify the most effective IPC integration models for different healthcare settings [14].
Various desirable skills among IPC personnel were highlighted, from first-hand clinical experience (nursing, medicine), epidemiology, microbiology, data science, implementation and behaviour science, leadership, project management, organisational management, and complexity science to communication and marketing skills. Considering this wide range of topics, IPC teams—and even healthcare institutions—will be challenged to integrate all this expertise. Astonishingly, the organisational challenge regarding how so many skills would be taught to and mastered by future IPC professionals was not addressed in the ‘open research’ question. In principle, this broad array of know-how and expertise could be covered by interdisciplinary IPC teams with specifically trained and certified experts, as recently showcased [15]; alternatively, healthcare organisations would have to provide access to the corresponding subject experts as transversal resources of the institution. Each solution has advantages and challenges, and these alternative futures have yet to be explored.
The large number of statements matching the leitmotif “behaviour change and implementation” reflects the increasing importance attributed to the behavioural determinants of suboptimal execution of IPC measures. Behavioural aspects were considered key for the sustainability of quality improvement efforts. Techniques mentioned in this survey included role modelling, innovative education methods such as hypermediaFootnote 1 learning and virtual reality [10], nudging [16], implementation science [17], social media [18], monitoring and feedback [19], incentives and reprisal, team science [20], but also classical PDSA cycles.
The potential benefit and the many risks of electronic communication, e.g., the metaverse, were not explicitly mentioned by the respondents [21].
Others have previously addressed the future development of IPC. For example, a recurrent think tank exercise during the biannual Conference on Prevention and Infection Control held in Geneva, Switzerland, has generated three papers [22,23,24]. The first promoted optimising implementation in IPC [23]; the second focused on technology in the fields of microbiome research, whole genome sequencing, antimicrobial surfaces, and hand hygiene [24]; and the third advocated for global networks to tackle surveillance, antimicrobial stewardship, and research and development [22]. While not strictly using Futures research methods, such think tanks are certainly future-oriented and provide a higher flight-level view of IPC. Some participants of this survey also participated in the Geneva think tanks. Andreas Voss, a vocal advocate for IPC (not participating in this survey), wrote a short opinion monograph on IPC's future, explicitly discussing the post-COVID-19 time [25]. He addressed the shift to long-term care, advocated for harmonised policies across the entire healthcare system, and consequently identified the need for IPC to leave the hospital ‘silo’ behind, extending the scope of IPC to ‘health and lifestyle’ with big players such as Google, Apple, and Amazon and their data analysis capabilities and capacities. The digital and artificial intelligence progress provide new opportunities. The built environment also offers opportunities with its physical (surfaces, controlled airflow) and behavioural (no-touch design) and cognitive properties (‘knowledge in the world’).
This survey specifically addressed the mid-term future of IPC in the next decade. It provides a broad and in-depth view by an international panel of senior IPC experts that was based on a formal qualitative analysis to elicit relevant themes. It forms an exciting starting point and provides a frame of reference on which to build. We hope that the Crystal Ball Initiative will be able to carry this exploration further in an iterative and evolutive manner. For example, as an expression of a more structured and balanced practical approach, the Association of Professional Futurists (https://www.apf.org) has developed a ‘foresight competency model’ that suggests an iterative investigation [26]. Another reality-enhancing method would be to look at the present from the perspective of an already fulfilled future as employed in qualitative research [27]. Furthermore, we could consider including a larger band of experience and specialities beyond IPC, such as human factors engineers [28].
This study has limitations. The response rate was fair, and the number of participants was limited. There was a bias toward participation from the USA, a predominance of experience in acute care, in high-income countries, and an academic physician background. However, the bias favouring innovative thinking and longstanding expertise was deliberate – even if the selection was not exhaustive. An ‘experiential Futures’ research method—accommodating participants in physically simulated future environments [6]—would perhaps have evoked a more thorough and detailed vision of more possible realities for IPC in 2030 than a self-administered online questionnaire [6].
Conclusions
This first survey within the Crystal Ball Initiative presented a nuanced perspective of potential futures, as elucidated by prominent global leaders in IPC. The outlook was largely positive, harnessing the advancements in technology and medicine to enhance effectiveness and liberating IPC professionals to actively engage at the point of care. This approach, fostered by the active involvement of IPC professionals in both local and global leadership and by adopting a diverse range of skills, will facilitate the seamless integration and expansion of IPC. Future Crystal Ball exercises should aspire to immerse participants more deeply into various scenarios to obtain a more comprehensive picture of the possible realities and involve participants in low- and middle-income countries and professionals who can assess the situation from the outside. Futures research could be pivotal for IPC to plan structures, resources, and education already in the mid-term.
Availability of data and materials
Data are partially included in this manuscript as quotes from survey responses; the complete survey answers are not made public for anonymity reasons.
Notes
Hypermedia: Nonlinear medium of information that includes graphics, audio, video, plain text and hyperlinks (Wikipedia).
Abbreviations
- COVID-19:
-
Coronavirus infectious disease 2019
- HAI:
-
Healthcare-associated infections
- IPC:
-
Infection prevention and control
- IT:
-
Information technology
- PDSA:
-
Plan-Do-Study-Act (i.e., cycles of quality improvement)
- RFID:
-
Radio frequency identification
- Q1 – Q4:
-
Question 1 to question 4
- SARS-CoV-2:
-
Severe acute respiratory syndrome coronavirus 2
- USA:
-
United States of America
- UK:
-
United Kingdom
References
Schiavone F, Ferretti M. The FutureS of healthcare. Futures. 2021;134:102849.
Schreiber PW, Sax H, Wolfensberger A, Clack L, Kuster SP, Swissnoso. The preventable proportion of healthcare-associated infections 2005–2016: Systematic review and meta-analysis. Infect Control Hosp Epidemiol. 2018;39:1277–95.
Bell W. Foundations of Futures Studies. Routledge; 2003.
Al-Rodhan N, Altman D, Barrabés C, Broecker W, Etzioni A, Fessel M, et al. There is a Future - Visions for a Better World. BBVA; 2012 [cited 2022 Nov 24]. Available from: https://www.bbvaopenmind.com/wp-content/uploads/2013/01/BBVA-OpenMind-Book-There-is-a-Future_Visions-for-a-Better-World-1.pdf
Glenn JC, Gordon TJ, editors. Futures Research Methodology — Version 3.0. The Millennium Project; 3.0 edition (April 30, 2009). ISBN-13: 978-0981894119. (https://www.millennium-project.org/publications-2/futuresresearch-methodology-version-3-0/).
Candy S. Experiential futures: Show and tell - Fly me to tomorrow. The Economist. 2015;3.
Infection Prevention Crystal Ball Initiative. Available from: https://www.saxhealthdesign.com/crystal-ball
Malterud K. Qualitative research: standards, challenges, and guidelines. The Lancet. 2001;358:483–8.
Breckwoldt J, Knecht M, Massée R, Flach B, Hofmann-Huber C, Kaap-Fröhlich S, et al. Operating room technician trainees teach medical students - an inter-professional peer teaching approach for infection prevention strategies in the operation room. Am Resist Infect Control. 2019;8:75.
Clack L, Hirt C, Wenger M, Saleschus D, Kunz A, Sax H. VIRTUE - A Virtual Reality Trainer for Hand Hygiene. Zakynthos, Greece: 2018 9th International Conference on Information, Intelligence, Systems and Applications (IISA); 2018. p. 1–2.
Calik A, Kapucu S. The Effect of Serious Games for Nursing Students in Clinical Decision-Making Process: A Pilot Randomized Controlled Trial. Games Health J. 2022;11:30–7.
Storr J, Kilpatrick C, Allegranzi B, Syed SB. Redefining infection prevention and control in the new era of quality universal health coverage. J Res Nurs. 2016;21:39–52.
Read B, McNulty CAM, Verlander NQ, Moss N, Lecky DM. Comparing public knowledge around value of hand and respiratory hygiene, vaccination, and pre- and post-national COVID-19 lockdown in England. Public Heal. 2022;212:76–83.
Brannigan ET, Murray E, Holmes A. Where does infection control fit into a hospital management structure? J Hosp Infect. 2009;73:392–6.
Weber DJ, Sickbert-Bennett EE, DiBiase LM, Brewer BE, Buchanan MO, Clark CA, et al. A new paradigm for infection prevention programs: An integrated approach. Infect Control Hosp Epidemiol. 2023;44:144–7.
Stangerup M, Kavalaris CP, From-Hansen M, Hansen MB, Hansen R, Hesselbo B, et al. Significantly Improved Hand Hygiene Compliance Using Nudging and Performance Feedback Based on Data from an Automated Monitoring System. Am J Infect Control. 2020;48:S56–7.
Gilmartin HM, Hessels AJ. Dissemination and implementation science for infection prevention: A primer. Am J Infect Control. 2019;47:688–92.
Cawcutt KA, Marcelin JR, Silver JK. Using social media to disseminate research in infection prevention, hospital epidemiology, and antimicrobial stewardship. Infect Control Hosp Epidemiol. 2019;40:1262–8.
Stewardson AJ, Sax H, Gayet-Ageron A, Touveneau S, Longtin Y, Zingg W, et al. Enhanced performance feedback and patient participation to improve hand hygiene compliance of health-care workers in the setting of established multimodal promotion: a single-centre, cluster randomised controlled trial. Lancet Infect Dis. 2016;16:1345–55.
Knobloch MJ, McKinley L, Keating J, Safdar N. Integrating antibiotic stewardship and infection prevention and control programs using a Team Science approach. Am J Infect Control. 2021;49:1072–4.
Fitzpatrick F, Doherty A, Lacey G. Using Artificial Intelligence in Infection Prevention. Curr Treat Options Infect Dis. 2020;12:135–44.
Zingg W, Storr J, Park BJ, Jernigan JA, Harbarth S, Grayson ML, et al. Broadening the infection prevention and control network globally; 2017 Geneva IPC-think tank (part 3). Antimicrob Resist Infect Control. 2019;8:1–5.
Zingg W, Storr J, Park BJ, Ahmad R, Tarrant C, Castro-Sánchez E, et al. Implementation research for the prevention of antimicrobial resistance and healthcare- associated infections; 2017 Geneva infection prevention and control (IPC)-think tank (part 1). Antimicrob Resist Infect Control. 2019;8:1–9.
Zingg W, Park BJ, Storr J, Ahmad R, Tarrant C, Castro-Sánchez E, et al. Technology for the prevention of antimicrobial resistance and healthcare- associated infections; 2017 Geneva IPC- Think Tank (Part 2). Antimicrob Resist Infect Control. 2019;8:1–5.
Voss A. BSAC Vanguard Series: The future of infection prevention and control: how COVID is already transforming our approach to antimicrobial resistance. J Antimicrob Chemoth. 2021;77:dkab416.
Hines A, Gary J, Daheim C, van der Laan L. Building Foresight Capacity: Toward a Foresight Competency Model. World Futur Rev. 2017;9:123–41.
Patton MQ. Qualitative Research and Evaluation Methods. 3rd Edition. Sage Publications, Inc. Thousand Oaks, California, USA. ISBN 978-0-7619-1971-1.
Sax H. Human factors engineering in infection prevention and control Hugo Sax. In: Elliott P, Storr J, Jeanes A, editors. Infection Prevention and Control: A Social Science Perspective. Routledge; 2023. Available from: https://www.routledge.com/Infection-Prevention-and-Control-A-Social-Science-Perspective/Elliott-Storr-Jeanes/p/book/9781032458380
Acknowledgements
The authors warmly thank Andrew Atkinson, Lauren Clack, Stefan P. Kuster, Matthias Schlegel, Peter W. Schreiber, and Aline Wolfensberger for brainstorming this survey.
The data were presented as a poster at the 6th International Conference on Prevention & Infection Control (ICPIC), 14–17 September 2021, in Geneva, Switzerland.
Crystal Ball Initiative members and coauthors of this study: Sue Barnes, Infection Prevention Consultant, San Mateo, CA USA; John M. Boyce, J.M. Boyce Consulting, LLC, Hyde Park, NY USA; Suzanne F. Bradley, Infectious Disease Section, Veterans Affairs Ann Arbor Healthcare System and Division of Infectious Diseases, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI USA; Dale Fisher, Department of Medicine, National University Hospital, Yong Loo Lin School of Medicine, National University of Singapore, Singapore; Andrea Grisold, Diagnostic and Research Institute of Hygiene, Microbiology and Environmental Medicine, Medical University Graz, Graz, Austria; Stephan Harbarth, Division of Infection Prevention and Control, Geneva University Hospital and Faculty of Medicine, University of Geneva, Geneva, Switzerland; Anita Huis, Department of Primary and Community Care, Research Institute for Medical Innovation, 'Radboud university medical center, Nijmegen, The Netherlands; Elaine Larson, School of Nursing, Mailman School of Public Health, Columbia University, New York Academy of Medicine, New York City, NY USA; Andie Lee, Departments of Infectious Diseases and Microbiology, Royal Prince Alfred Hospital, Sydney Medical School, University of Sydney, Sydney, Australia; Grace Lee, Stanford Medicine Children’s Health, Stanford University School of Medicine, Stanford, CA USA; Yves Longtin, Infection Prevention and Control Unit, Jewish General Hospital, McGill University, Montreal, Canada; Jean-Christophe Lucet, Infection Control Unit, Bichat-Claude Bernard University Hospital, Paris, France; Jonas Marschall, Division of Infectious Diseases, John T. Milliken Department of Internal Medicine, Washington University School of Medicine, St Louis, MO, USA; Eli Perencevich, University of Iowa Carver College of Medicine, Iowa City, IA, USA; Hugo Sax, Department of Infectious Diseases, Bern University Hospital, University of Bern, Bern, Switzerland; Simone Scheithauer, Department of Infection Control and Infectious Diseases, University Medical Centre Göttingen, Germany; Julie Storr, KS Healthcare Consulting, UK; Jason-Anthony Tetro, Scientific Consultant, Edmonton, Canada; Erich Tschirky, Swiss Center for Infection Prevention Swissnoso, Bern, Switzerland; Diana Vilar-Compte, Department of Infectious Diseases, Instituto Nacional de Cancerologia, Mexico City, Mexico.
Funding
None.
Author information
Authors and Affiliations
Consortia
Contributions
All authors contributed to determining/confirming the method, validating the results, and revising the manuscript. H.S. and J.M. performed the analysis and wrote the manuscript.
Corresponding authors
Ethics declarations
Ethics approval and consent to participate
This study does not fall under the Swiss law on research on humans. Furthermore, since the respondents to the survey are all authors of this study, their consent is implicit.
Consent for publication
All authors have given consent for submission and potential publication of this manuscript.
Competing interests
None declared by all authors.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Sax, H., Marschall, J. & and the Crystal Ball Initiative. Infection prevention and control in 2030: a first qualitative survey by the Crystal Ball Initiative. Antimicrob Resist Infect Control 13, 88 (2024). https://doi.org/10.1186/s13756-024-01431-3
Received:
Accepted:
Published:
DOI: https://doi.org/10.1186/s13756-024-01431-3